Crossmark

CLL: Therapiewahl bei Vorhofflimmern und Blutungsrisiko

Crossref DOI link: https://doi.org/10.1007/s15015-022-3822-2

Published Online: 2022-04-05

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Springer, Günter
License Information

Text and Data Mining valid from 2022-04-01

Version of Record valid from 2022-04-01
More Information

Article History

First Online: 5 April 2022

Free to read: This content has been made available to all.